No Detail Found!

Frequency and Clinical importance of Anti-Tg auto-antibodies (ATG).

Author(s)
Allah Rakha Adil Department of Nuclear Medical, LINAR (Larkana Institute of Medicine and Radiotherapy, Larkana, Pakistan
A. Rafaqat Jafri Department of Nuclear Medicine, NORI Nuclear Medicine, Oncology, Radiotherapy Institute, Islamabad, Pakistan
Amin Waqar Department of Nuclear Medicine, AFIP, Armed Forces Institute of Pathology, Rawalpindi, Pakistan
A. Siraj Abbsi Department of Radiotherapy, LINAR Larkana Institute of Nuclear Medicine and Radiotherapy, Larkana, Pakistan
Matiul Haq Thyroid Laboratory, IRNUM Institute of Radiotherapy and Nuclear Medicine Peshawar, Pakistan
H. A. Asghar Department of Nuclear Medicine, IRNUM Institute of Radiotherapy and Nuclear Medicine, Peshawar, Pakistan
Asif Jilani Department of Nuclear Medicine, IRNUM Institute of Radiotherapy and Nuclear Medicine, Peshawar, Pakistan
Irum Naz Department of Nuclear Medicine, IRNUM Institute of Radiotherapy and Nuclear Medicine, Peshawar, Pakistan
Abstract
To note the frequency of anti thyroglobulin autoantibodies (ATG) and its clinical importance in 25 follow-up cases of differentiated thyroid cancer (DTC). A case control study was conducted for one year (September 2000 to August 2001). Majority of the patients included were the routine follow-up cases at IRNUM, Peshawar. However, few of the cases were also included from NORI, Islamabad and AFIP, Rawalpindi. All the patients who had undergone sub-total or total thyroidectomy followed by 1-131 ablation therapy were selected for this study. Thyrogolobulin (Tg) and ATG were measured using immunometric assay technique with reference range of non-detectable to 40 IU/L. Patients with serum Tg Level > 10 ng/mL were included in group-1 (n=15) and all the remaining (n=10) in group-2. Overall, 11 patients showed ATG titer above the pre-define threshold level. In group-1 patients, 8 had positive anti-Tg antibodies in their sera while in group-2, it was positive in only 3 cases. Risk of relapsing metastatic/recurrent disease in association with ATG was calculated which showed that patients with positive ATG have almost seven-fold increased risk of having recurrent/metastatic disease than those who do not. Sample for s-Tg measurements must also be evaluated for ATG status because more than one-third of these patients have positive ATG, titer in there sera. Although in the presence of positive ATG the risk of concurrent metastatic/recurrent thyroid disease is increased but still more studies are required to support its significance.
Publication Details
Page(s) 504-506
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 13, Issue: 9, Year: 2003

Request the full text from PASTIC

0

Citations

0

Downloads

112

Views